Madison Avenue Partners, LP Lensar, Inc. Transaction History

Madison Avenue Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.02 - $4.45 $353,708 - $521,192	-117,122 Reduced 32.76%	240,341 $742,000
Q2 2023 Aug 14, 2023	SELL	$2.3 - $4.34 $716,640 - $1.35 Million	-311,583 Reduced 46.57%	357,463 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$4.94 - $7.0 $34,891 - $49,441	-7,063 Reduced 1.04%	669,046 $3.71 Million
Q1 2021 May 17, 2021	BUY	$6.28 - $9.56 $244,298 - $371,893	38,901 Added 6.1%	676,109 $4.91 Million
Q4 2020 Feb 12, 2021	BUY	$6.7 - $12.2 $4.27 Million - $7.77 Million	637,208 New	637,208 $4.62 Million

4.84M

1.5K

19.4K

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $49.6M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

Get notified when there are updates to the investment portfolio of Madison Avenue Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Madison Avenue Partners, LP with notifications on news.